When the disease appears later in life, it is referred to as acquired hemophilia. Appropriate treatment can control hemophilia in these instances. There is a possibility that the disease can ...

Although uncommon, hemophilia can develop later in life (called acquired hemophilia) due to hemorrhagic immune system disorders unrelated to inherited forms. Hemophilia A is caused by a deficiency ...

There are two main types of hemophilia - Hemophilia A (due to factor VIII deficiency) and Hemophilia B (due to factor IX deficiency). They are clinically almost identical and are associated with ...

The US Food and Drug Administration has approved fitusiran for bleeding prophylaxis in hemophilia A and B with or without ...

Fitusiran antithrombin-based dose regimen targeting 15%-35% of antithrombin activity demonstrated favorable safety profile in male participants aged ≥ 12 years with severe hemophilia A or B ...

About two-thirds of type A and B cases of hemophilia occur in people with a family history of the condition. It’s also possible to develop acquired hemophilia with no personal or family history ...